Quick Answer
PAVmed Inc. reported Total Assets of $38.81 million for the year ending 2025.
- PAVmed Inc. showed an increase of +26.6% in Total Assets from 2024 to 2025.
- This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: $3.15 million | Q3 2016: $1.99 million | Q1 2017: $1.09 million | Q2 2017: $226.5 thousand | Q3 2017: $3.23 million | Q1 2018: $3.76 million | Q2 2018: $11.24 million | Q3 2018: $9.40 million | Q1 2019: $4.36 million | Q2 2019: $7.06 million | Q3 2019: $4.41 million | Q1 2020: $10.11 million | Q2 2020: $8.88 million | Q3 2020: $10.50 million | Q1 2021: $51.37 million | Q2 2021: $47.37 million | Q3 2021: $42.99 million | Q1 2022: $84.33 million | Q2 2022: $82.45 million | Q3 2022: $72.47 million | Q1 2023: $65.29 million | Q2 2023: $53.68 million | Q3 2023: $42.02 million | Q1 2024: $37.25 million | Q2 2024: $39.41 million | Q3 2024: $30.55 million | Q1 2025: $52.82 million | Q2 2025: $43.89 million | Q3 2025: $38.07 million.
- Over the full 11 years of available data (2015 to 2025), PAVmed Inc.'s Total Assets has grown by 3,096.8%.
- Historical annual values: Fiscal year 2025: $38.81 million | Fiscal year 2024: $30.66 million | Fiscal year 2023: $33.12 million | Fiscal year 2022: $53.98 million | Fiscal year 2021: $86.98 million | Fiscal year 2020: $19.78 million | Fiscal year 2019: $7.24 million | Fiscal year 2018: $8.50 million | Fiscal year 2017: $1.64 million | Fiscal year 2016: $870.4 thousand | Fiscal year 2015: $1.21 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: